Two former Pfizer executives published a statement saying they support management as it gets pressured for changes by activist investor Starboard Value. The ex-Pfizer executives, Ian Read and ...

This article Former Pfizer Executives Ian Read And Frank D'Amelio Support Albert Bourla's Leadership Amid Starboard Activism: 'Will Deliver Shareholder Value' originally appeared on Benzinga.com.

Former Pfizer Inc PFE CEO Ian Read and ex-CFO Frank D’Amelio have decided to distance themselves from the activist campaign led by Starboard Value at the pharmaceutical giant.

Pfizer has found a successor for Chief Scientific Officer and R&D head Mikael Dolsten, M.D., Ph.D., tapping the company’s own Chris Boshoff, M.D., Ph.D., for the job and prompting a domino-effe ...

Pfizer Inc. is conducting a Phase 1B clinical trial titled ‘A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory ...

Dolsten’s decision will bring to an end a 15-year career at Pfizer, which began with the company’s acquisition in 2009 of Wyeth, at which he served as president and head of R&D.

NEW YORK, December 05, 2024--Pfizer Inc. (NYSE: PFE) will highlight the latest advancements from its growing hematology and breast cancer portfolios at the American Society of Hematology (ASH ...

Data4Cure today announced an ongoing multi-year partnership with Pfizer, aimed at leveraging advanced analytics and knowledge graph AI to drive innovation in Pfizer's drug discovery and ...

He also praises Pfizer's approach to delivering comprehensive care rather than just selling medications. Can you share insights on how your recently partnership with Pfizer is helping to navigate ...

Overall Count and Share for 'Pfizer UAE' based on the 12-month time frame mentioned above. Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research ...

Pfizer Inc. will highlight the latest advancements from its growing haematology and breast cancer portfolios at the American Society of Haematology (ASH) Annual Meeting & Exposition (December 7-10) ...